RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 25 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $0 | – | 1,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,018,409 | $1,355,000 | 0.13% |
| TWO SIGMA SECURITIES, LLC | 14,471 | $4,000 | 0.01% |
| Virtu KCG Holdings LLC | 160,446 | $43,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,646 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 16,000 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 171 | $0 | 0.00% |
| NORTHERN TRUST CORP | 12,744 | $3,000 | 0.00% |
| UBS Group AG | 22,559 | $6,000 | 0.00% |
| CITIGROUP INC | 28 | $0 | 0.00% |
| GOLDMAN SACHS GROUP INC | 19,616 | $5,000 | 0.00% |